Wilmington Investor Network

Tunnel allows real-time global cross-currency payments for free using our Distributed Ledger Technology. We provide our own payment rails, APIs and mobile apps.

Roobrik, Inc. is an online platform founded in 2013 and based in Greensboro, North Carolina. The company specializes in providing decision-making tools designed to assist caregivers, senior care providers, and clinicians in navigating health and care choices. By offering resources that empower older adults and their families, Roobrik facilitates informed decision-making and helps users connect with various products, services, and programs to meet their needs.

Respiratory Motion, Inc. is a medical device company that specializes in the development and commercialization of respiratory monitoring technologies. Headquartered in Waltham, Massachusetts, the company focuses on its flagship product, ExSpiron, a point-of-care device designed to non-invasively measure and provide quantitative values for key respiratory parameters, including minute ventilation, tidal volume, and respiratory rate. The ExSpiron has received FDA clearance, allowing it to graphically display lung volumes over time, thereby enabling healthcare providers to acquire precise data on patients’ respiratory function. Founded in 2010, Respiratory Motion aims to enhance the standard of care in respiratory monitoring while improving patient safety and outcomes through cost-effective solutions.

MTI, a smart materials and photonics company which is changing the way we use, interact and benefit from light. From healthcare to defense, energy to aerospace– the possibilities are endless

Avhana Health Inc. provides an application to simplify the healthcare provider workflow by offering the latest guidelines, actionable recommendations, and performance metrics—directly in their EHR. Its application features a dashboard for pre-visit planning, patient-specific recommendations for care, corresponding order suggestions that submit to the EHR, and a dashboard for tracking provider activity and performance. The company was founded in 2014 and is based in Baltimore, Maryland.

Validic, Inc. is a healthcare technology company that specializes in a cloud-based platform designed to collect and manage mobile health data from various Internet-enabled applications and devices. Founded in 2010 and headquartered in Durham, North Carolina, Validic provides solutions such as Validic Solution, which connects patient-recorded data from digital health applications and wearables to healthcare providers; Validic Connect, which offers access to less common clinical and consumer devices; and Validic Mobile, focused on data collection from digital health apps and in-home devices. The platform simplifies the management of personal health data, enabling wellness companies, healthcare providers, pharmaceuticals, and health plans to access and utilize this information effectively.

Gemmus Pharma Inc. is a biotechnology company based in San Francisco, California, founded in 2007. The company focuses on developing therapeutics for the treatment of influenza and other infectious diseases. Its lead candidates include GP1001, a non-peptidic eicosanoid analog designed for serious influenza infections that may require hospitalization, and GP1681, which aims to alleviate influenza symptoms by reducing the exaggerated cytokine response induced by the virus. GP1001 can be used as a stand-alone treatment or in combination with antiviral drugs such as oseltamivir. Gemmus Pharma has received support from the National Institute of Allergy and Infectious Disease and has plans to file an investigational new drug application with the FDA to advance its influenza treatment initiatives.

Trusted Metrics Inc. is an information security company based in Raleigh, North Carolina, founded in 2010. The company specializes in a cloud-based security incident and event management platform known as Elastic SOC®, which allows organizations to effectively monitor and manage their cybersecurity needs. This platform consolidates various security functions such as log correlation, intrusion detection, asset management, vulnerability management, and threat intelligence into a single interface, making it particularly beneficial for managed service providers and managed security service providers. Trusted Metrics provides tools for real-time threat analysis, customizable reporting, and long-term forensic analysis, enabling clients to maintain visibility and rapid response capabilities across their networks. The company serves a diverse range of sectors, including local government, higher education, healthcare, and manufacturing. Trusted Metrics operates as a subsidiary of SolarWinds Worldwide, LLC, and has received recognition as a Red Herring Global 100 Finalist and among CRN's Coolest Emerging Vendors.

ABK Biomedical Inc., founded in 2012 and based in Halifax, Canada, develops innovative embolotherapeutic products aimed at treating uterine fibroids, hypervascular tumors, and arteriovenous malformations. The company focuses on enhancing interventional radiology procedures, particularly embolization, by combining clinical market insights with advanced biomaterials. ABK Biomedical's flagship product is a novel radiopaque microsphere designed to improve the targeting of tumor blood vessels and tissue. This technology not only aids in the standardization and optimization of minimally invasive therapies but also facilitates personalized treatment options for patients with complex conditions. Through its commitment to advancing embolotherapy, ABK Biomedical seeks to transform patient care in the field of interventional radiology.

ChaoLogix, Inc. develops computing architecture and chip sets. It offers Chaologix system, a processor and architecture, based on chaotic circuit elements. This system is used in desktop and laptop personal computers, reconfigurable computer video cards for multimedia and gaming, computer network routers, chaotic search engine hardware, power cell phones, and light and adaptable avionics and satellite hardware. Its Chaologix system is also used in specialty computer chips, smart and low power medical devices, robotics, NASA and Department of Defense applications, speedier graphics cards, and self-healing and self-repairing computers. ChaoLogix was founded in 2005 and is based in Gainesville, Florida.

Gemmus Pharma Inc. is a biotechnology company based in San Francisco, California, founded in 2007. The company focuses on developing therapeutics for the treatment of influenza and other infectious diseases. Its lead candidates include GP1001, a non-peptidic eicosanoid analog designed for serious influenza infections that may require hospitalization, and GP1681, which aims to alleviate influenza symptoms by reducing the exaggerated cytokine response induced by the virus. GP1001 can be used as a stand-alone treatment or in combination with antiviral drugs such as oseltamivir. Gemmus Pharma has received support from the National Institute of Allergy and Infectious Disease and has plans to file an investigational new drug application with the FDA to advance its influenza treatment initiatives.

OncoHealth is a company that specializes in creating screening devices aimed at the detection and diagnosis of cancer. The primary focus of its devices is the development of protein bio-markers, which are essential for the screening and diagnostic processes related to cervical cancer and other cancers associated with human papillomavirus (HPV). By advancing these technologies, OncoHealth enables medical professionals to effectively monitor, diagnose, and treat cancer, thereby contributing to improved patient outcomes in oncology.

Pique Therapeutics, Inc. is a biopharmaceutical company based in Durham, North Carolina, founded in 2005. The company specializes in the development of therapeutic vaccines aimed primarily at treating various types of cancer, including non-small cell lung, colorectal, head and neck, and pancreatic cancers. With a focus on advancing innovative cancer treatments, Pique Therapeutics seeks to establish itself as a leader in the field of therapeutic vaccines.

Basho Technologies, Inc. specializes in providing NoSQL database solutions designed for enterprise-scale applications, particularly for Fortune 50 companies. The company’s flagship products include Riak, a distributed NoSQL database that efficiently manages unstructured data across clusters, and Riak CS, a cloud storage solution that supports public, private, and hybrid cloud environments. Basho's offerings also encompass Riak TS for handling time series data, as well as various add-ons like Apache Spark for real-time analytics and Apache Solr for search index synchronization. These tools are aimed at enhancing the performance and scalability of applications in sectors such as gaming, healthcare, retail, telecommunications, and technology. In addition to its software solutions, Basho provides services including implementation, training, and custom analytics. Founded in 2002 and headquartered in Bellevue, Washington, Basho Technologies has evolved from its original name, Basho Strategies Inc., in 2008.

Basho Technologies, Inc. specializes in providing NoSQL database solutions designed for enterprise-scale applications, particularly for Fortune 50 companies. The company’s flagship products include Riak, a distributed NoSQL database that efficiently manages unstructured data across clusters, and Riak CS, a cloud storage solution that supports public, private, and hybrid cloud environments. Basho's offerings also encompass Riak TS for handling time series data, as well as various add-ons like Apache Spark for real-time analytics and Apache Solr for search index synchronization. These tools are aimed at enhancing the performance and scalability of applications in sectors such as gaming, healthcare, retail, telecommunications, and technology. In addition to its software solutions, Basho provides services including implementation, training, and custom analytics. Founded in 2002 and headquartered in Bellevue, Washington, Basho Technologies has evolved from its original name, Basho Strategies Inc., in 2008.

Sensory Analytics, LLC develops advanced sensory solutions for precise measurement in various industrial applications, focusing on color and thickness measurement as well as process control. The company's flagship product line, SpecMetrix, includes automated and portable systems that deliver real-time, non-contact measurement of coating thickness, color, and other quality metrics. These systems provide continuous data with high precision, enabling industries such as aerospace, automotive, coatings, electronics, packaging, medical, and pharmaceuticals to enhance quality assurance and optimize production processes. Founded in 2004 and based in Greensboro, North Carolina, Sensory Analytics aims to improve process control and product quality while reducing operational costs through innovative measurement technologies.

Consolidated Asset Recovery Systems, Inc., based in Raleigh, North Carolina, specializes in software solutions for repossession management and asset recovery. Founded in 2005 by industry veterans, the company has developed the Internet Based Electronic Asset Management (IBEAM) system, which assists banks and dealers in tracking and recovering assets. Its range of services includes repossession management, remarketing, electronic invoice payment, skip tracing, audits, legal demand letter creation, and field assistance. The company operates a vast network of recovery agents across the United States, serving lenders, dealers, and recovery agents. Since its inception, Consolidated Asset Recovery Systems has experienced significant growth and has established itself as a leader in the repossession and remarketing industry, recognized for its compliance and flexibility in adapting to clients' needs. As of 2019, it operates as a subsidiary of Primeritus Financial Services, Inc.

Amulet Pharmaceuticals discovers and develops novel therapeutics using their NORTECHâ„¢ technology to address known liabilities of current therapies serving large unmet markets. Their lead program (AMU-301) treats diabetic gastroparesis an unmet complication of diabetes affecting over 3 million women in the United States.

At Wilmington Pharmaceuticals, they develop and out-license patient-friendly, fast-dissolving formulations for established medicines. They achieve FDA approval and rapid commercialization for their licensing partners, minimizing regulatory risk while maximizing economic opportunity. Their points of differentiation provide you with an ideal development partner.

Affinergy, LLC develops products that purify, concentrate, and remove cells and proteins from tissues and fluids for diagnostic and research applications. It develops a phage display platform that identifies peptides that bind to a variety of targets, such as drugs, proteins, and cells. The company’s products also include implantable devices that deliver and retain biologics at the site of implant in orthopedic procedures and soft tissue repair. The company was founded in 2003 and is based in Durham, North Carolina.